131 results on '"Nordestgaard, Børge G"'
Search Results
2. SGLT2-inhibition increases total, LDL, and HDL cholesterol and lowers triglycerides: Meta-analyses of 60 randomized trials, overall and by dose, ethnicity, and drug type
3. Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trial
4. Elevated plasma apolipoprotein E levels in people living with HIV: Associations with biomarkers and HIV-specific risk factors
5. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis
6. APOE and vascular disease: Sequencing and genotyping in general population cohorts
7. Triglyceride content increases while cholesterol content decreases in HDL and LDL+IDL fractions following normal meals: The Copenhagen General Population Study of 25,656 individuals
8. Plasma TSH and cardiovascular disease in the general population: A Mendelian randomization study of 105,224 individuals
9. Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society
10. Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality
11. Coronary artery- and aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms
12. Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: The Copenhagen General Population Study
13. Self-reported and genetically predicted coffee consumption and smoking in dementia: A Mendelian randomization study
14. Associations between body mass index trajectories in childhood and cardiovascular risk factors in adulthood
15. AHRR hypomethylation as an epigenetic marker of smoking history predicts risk of myocardial infarction in former smokers
16. Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM
17. A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals
18. Nonfasting versus fasting lipid profile for cardiovascular risk prediction
19. The Christmas holidays are immediately followed by a period of hypercholesterolemia
20. The importance of nonobstructive plaque characteristics in symptomatic and asymptomatic coronary artery disease.
21. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
22. Possible early detection of coronary artery calcium progression in type 1 diabetes: A case-control study of normoalbuminuric type 1 diabetes patients and matched controls
23. Extent of undertreatment and overtreatment with cholesterol-lowering therapy according to European guidelines in 92,348 Danes without ischemic cardiovascular disease and diabetes in 2004–2014
24. How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)?
25. Plasma YKL-40 levels in healthy subjects from the general population
26. Plasma immunoglobulin E and risk of exacerbation and mortality in chronic obstructive pulmonary disease: A contemporary population-based cohort.
27. Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association.
28. Reply to: “Seasonal variations of lipid profiles in a French cohort”
29. Reply to: “Methodological issues regarding: “A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals””
30. Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease: A Mendelian Randomization Study.
31. Elevated Lipoprotein(a) and Risk of Ischemic Stroke.
32. Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association.
33. Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.
34. Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population Study.
35. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: Two prospective cohort studies
36. Low 25-hydroxyvitamin d, blood pressure, hypertension, and ischemic stroke: a mendelian randomization study of 109662 individuals from the general population
37. Reply to: “Appropriate use of cholesterol-lowering therapy”
38. A Test in Context: Lipid Profile, Fasting Versus Nonfasting.
39. Corrigendum to Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association [Journal of Clinical Lipidology Volume 13, Issue 3, May–June 2019, Pages 374-392].
40. P-wave duration and the risk of atrial fibrillation: Results from the Copenhagen ECG Study.
41. Milk intake is not associated with low risk of diabetes or overweight-obesity: a Mendelian randomization study in 97,811 Danish individuals.
42. Genetically high plasma vitamin C, intake of fruit and vegetables, and risk of ischemic heart disease and all-cause mortality: a Mendelian randomization study.
43. Tobacco smoking and aortic aneurysm: Two population-based studies.
44. Plasma 25-Hydroxyvitamin D and Risk of Non-Melanoma and Melanoma Skin Cancer: A Prospective Cohort Study.
45. Sex- and age-related differences of myocardial perfusion at rest assessed with multidetector computed tomography.
46. Prostate-Specific Antigen and Long-Term Prediction of Prostate Cancer Incidence and Mortality in the General Population▪
47. Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?: A Mendelian Randomization of 47,000 Individuals From the General Population
48. PCSK9 R46L, Low-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart Disease: 3 Independent Studies and Meta-Analyses
49. Two novel mutations in surfactant protein-C, lung function and obstructive lung disease.
50. Elevated ACE activity is not associated with asthma, COPD, and COPD co-morbidity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.